pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,734 catalysts · 18,987 approval · 5,347 phase readout · 5,000 device 510k · 4,728 grant · 2,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: grant×type: filing×clear all
type
  • approval18,987
  • phase readout5,347
  • device 510k5,000
  • grant4,728
  • 8k filing2,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • pdufa347
  • therapy area
    • Ophthalmology5

    Week of Apr 13, 2026

    28
    ›Apr 15, 2026grant110d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Impact of Host Genetic Variants on Regulating Chikungunya Virus-Induced Disease

    AI grant. $229,360. PI: Mark T Heise

    full page →nih reporter ↗
    ›Apr 15, 2026grant110d agoINDIANA UNIVERSITY INDIANAPOLIS — Advancing Alzheimer's Disease research through a preclinical model of SERPINA3Metallomix Inc

    AG grant. $435,875. PI: Stephane Pelletier

    full page →nih reporter ↗
    ›Apr 15, 2026grant110d agoWISTAR INSTITUTE — Investigating BCAA oxidation and signaling in macrophages to drive anti-tumor...

    CA grant. $780,764. PI: Rahul Suresh Shinde

    full page →nih reporter ↗
    ›Apr 15, 2026grant110d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Enabling Novel Strategies for the Clinical Care of Urinary Tract Infection vi...

    DK grant. $86,874. PI: Alexandra Patterson

    full page →nih reporter ↗
    ›Apr 15, 2026grant110d agoGORDON RESEARCH CONFERENCES — 2026 Intrinsically Disordered Proteins Gordon Research Conference and Gordon ...

    EB grant. $10,000. PI: Shahar Sukenik

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoJOHNS HOPKINS UNIVERSITY — Blood-Brain Barrier Integrity and Immune Dynamics in Neuropsychiatric Sequela...Johns Hopkins University

    NS grant. $633,378. PI: Alba Miranda Azola

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF WASHINGTON — Development of molecular tools and mouse models to study neglected Sindbis vi...University of Washington

    AI grant. $88,250. PI: Jennifer Lynn Hyde

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF MARYLAND BALTIMORE — Epigenetic regulation of neo-sex chromosomes in filarial parasites

    AI grant. $440,211. PI: Julie Dunning Hotopp

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF TEXAS ARLINGTON — CONNECT: Cohort-Oriented Network kNowledgebase for Enhanced CollaboraTion

    ES grant. $605,091. PI: Yike Shen

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoGEORGETOWN UNIVERSITY — Epigenetic Biomarkers in Glioblastoma

    NS grant. $429,000. PI: NAGI G AYAD

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoEMORY UNIVERSITY — Understanding Multidrug-Resistant Pathogen Infections and their Treatment wit...Emory University

    AI grant. $161,244. PI: TERESA GIL GIL

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF PENNSYLVANIA — Metabolic Imaging Using Hyperpolarized Agents at Tracer ConcentrationsUniversity of Pennsylvania

    CA grant. $415,623. PI: STEPHEN J KADLECEK

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoBOSTON CHILDREN'S HOSPITAL — Molecular Mechanisms of Aire in Transcriptional RegulationBoston Children's Hospital

    AI grant. $267,000. PI: Qianxia Zhang

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — The molecular and physiologic effects of calcineurin inhibitors on WNK body b...

    DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Examining the Effectiveness of School-based Health Centers (SBHCs) to Improve...

    NR grant. $3,480,544. PI: Michelle Trivedi

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Volatile Organic Compound Impacts on Immune Functions During Pregnancy: Molec...

    ES grant. $795,869. PI: Sean M Harris

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoLOUISIANA STATE UNIV HSC SHREVEPORT — The role of ZBP1 in controlling HSV-1 pathogenesis

    AI grant. $660,723. PI: Hongyan Guo

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Determinants of viral assembly and infectivity within the Ebola virus VP24 pr...

    AI grant. $843,182. PI: Christopher F Basler

    full page →nih reporter ↗
    ›Apr 16, 2026grant109d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — The effects and mechanisms supporting psilocybin induced pain reliefUniversity of California San Diego

    AT grant. $788,967. PI: ADAM L. Halberstadt

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoUNIVERSITY OF WASHINGTON — Mentoring patient-oriented research on point-of-care diagnostics for infectio...University of Washington

    AI grant. $209,758. PI: Paul K Drain

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Assessing multi-site feasibility of an integrated whole-body hyperthermia and...University of California San Francisco

    AT grant. $601,259. PI: Ashley E. Mason

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoUNIVERSITY OF SOUTH FLORIDA — Aligning Circuit-Directed Rehabilitation with HPA Axis for Improved TBI Recovery

    NS grant. $568,920. PI: Theresa Currier Thomas

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Disrupting the Peri-necrotic Engine of Immunosuppression in GlioblastomaNorthwestern University

    CA grant. $496,357. PI: DANIEL J BRAT

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoMASSACHUSETTS GENERAL HOSPITAL — Toolkit for Optimal Pain Management in the Emergency Department: A mind-body ...Massachusetts General Hospital

    AT grant. $170,640. PI: Julia E. Hooker

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Novel Pediatric TB Diagnostics using Host and Microbial Biomarkers

    AI grant. $210,302. PI: William Evan Johnson

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Remote Loading of Melanocortin and GLP-1 Peptides in Polymers for Treatment o...

    DK grant. $231,000. PI: Roger D. Cone

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoRESEARCH TRIANGLE INSTITUTE — Development of Neuromedin Receptor 2 antagonists as Novel Analgesics

    NS grant. $230,562. PI: Thuy Nguyen

    full page →nih reporter ↗
    ›Apr 17, 2026grant108d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smo...University of California San Francisco

    ES grant. $117,747. PI: Rebecca Sugrue

    full page →nih reporter ↗

    Week of Apr 27, 2026

    6
    ›Apr 30, 2026filing95d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing
    ← prev
    page 95 of 95
    next →
    95d ago
    Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Choroidal Neovascularization

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing95d agoSarepta Therapeutics Inc — golodirsen (NDA/BLA Filing (US))golodirsen

    Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy

    full page →golodirsen →source: globaldata
    ›Apr 30, 2026filing95d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing95d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Diabetic Retinopathy

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing95d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Diabetic Macular Edema

    full page →ranibizumab biosimilar →source: globaldata
    $SRPT14.86-4.50%